Helsinki, Finland – MVision AI, a leading provider of AI-powered solutions for radiation therapy treatment planning, announces the appointment of Saad Ullah Akram as its new Chief Executive Officer. Known for its commitment to streamlining workflows and enhancing treatment quality in cancer care, MVision AI is embarking on an exciting new chapter of growth and innovation under Saad’s leadership.
Saad Ullah Akram, PhD, a co-founder of MVision AI, brings over 10 years of expertise in deep learning for medical imaging. He has extensive global experience in AI development and cloud-based solutions. Saad’s unique combination of technical expertise, leadership in product innovation, and operational excellence has been instrumental in driving MVision AI’s success, making him ideally suited to lead the company into its next phase of growth and impact.
The leadership transition marks a pivotal moment for MVision AI to refocus its strategy and embrace new growth opportunities. With the collective support of the Board, Founders, and Investors, the company is energized to pursue a streamlined, long-term success and greater impact in the field of cancer care.
“I am honored and excited to take on this role at such a critical juncture for MVision AI,” said Saad Ullah Akram. “Our mission to advance cancer care through innovation has always been vital. Together with our talented team, we will focus on unlocking our full potential—delivering impactful solutions, building strong partnerships, and creating a sustainable future for our company and the patients we serve.”
The appointment of Pontus Stråhlman, representing a long-time and early institutional investor for MVision, as Board Chairperson further strengthens the company’s leadership team. Together, the leadership is aligned to steer MVision AI toward its ambitious goals and reaffirm its commitment to innovation in cancer care.
Saad succeeds Dharani Rangaraj, under whose leadership, the company achieved significant milestones and laid the groundwork for its next chapter. Dharani will continue to contribute to MVision AI as an advisor, ensuring a seamless transition.
About MVision AI
MVision AI is a leading provider of AI-powered solutions for radiation therapy treatment planning. Our mission is to empower Radiation Oncology professionals with cutting-edge technology to streamline workflows, enhance treatment quality, and enable more patient-focused care. Committed to innovation and excellence, MVision AI continues to advance cancer care through the power of AI.
Media Contact
Sakthy Edamaruku
Email: sakthy.edamaruku@mvision.ai
MVision AI Headquarters
Paciuksenkatu 29, 00270
Helsinki, Finland
